Skip to content

Remote Care: The Future of Cochlear Implants

Remote Care: The Future of Cochlear Implants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04721327
Enrollment
30
Registered
2021-01-22
Start date
2021-03-16
Completion date
2023-06-30
Last updated
2023-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cochlear Implants

Keywords

telemedicine, service delivery model

Brief summary

The purpose of this study is to see if remote programming visits for cochlear implants are possible.

Interventions

OTHERremote CI programming

provision of CI programming provided remotely via Zoom in a 2 hour session

Sponsors

Cochlear
CollaboratorINDUSTRY
University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Pediatric Arm 1. English speaking patients (Parents can speak English and/or Spanish) 2. ages 1-17 years 3. current CI users with a Cochlear Americas device 4. minimum of 6-months of CI experience 5. maximum of 4 years of CI experience Adult Arm 1. Postlingual patients 2. English speaking patients 2\. ages 18-90 years 3. current CI users with a Cochlear Americas device 4. minimum of 3-months of CI experience 5. maximum of 18-months of CI experience

Exclusion criteria

1. Patients with physical neuropathy, abnormal anatomy (e.g., cochlear malformations), severe cognitive deficits, and/or severe mental health difficulties 2. Patients who do not speak English 3. Patients who do not have access to the internet 4. Patients who do not live in Florida 5. Patients who have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.

Design outcomes

Primary

MeasureTime frameDescription
electrode impedancesup to 8 monthsmeasured via CI programming software (kOhm)
electrically evoked compound potential values (neural response telemetry)up to 8 monthsmeasured via CI programming software (mV)
dataloggingup to 8 monthsmeasured via CI programming software (hours per week)
stimulation levelsup to 8 monthsthreshold and upper stimulation levels measured via CI programming software (clinical unit)
auditory skills as measured by the LittleEars Questionnaireup to 8 monthsThe LittleEars auditory questionnaire (LEAQ) uses parent responses to assess auditory behavior in children up to 24 months of age. The questionnaire is scored from 0 to 35 with 0 indicating poorer performance and 35 indicating better performance.
auditory skills as measured by the Auditory Skills Checklist (ASC)up to 8 monthsASC has a Total Score ranges from zero to 70, with higher scores indicating development of increasingly complex listening skills
hearing disability as measured by the Speech, Spatial and Qualities Hearing Scale (SSQ)up to 8 monthsThe SSQ is a a 49 item self-report test of hearing disability across three main sections and 10 pragmatic subscales. The total score ranges from zero to ten, with a lower score indicating a higher degree of hearing disability

Secondary

MeasureTime frameDescription
Behavior Assessment System for Children, 3rd Edition (BASC-3)up to 8 monthsBASC-3 is scored 0-120 as a T score. Any scores between 60-70 is considered at risk / requires monitoring and scores greater than 70 are considered clinically significant / an area that likely requires therapeutic intervention.
Scale of Parental Involvement and Self-Efficacy-Revised (SPISE-R)up to 8 monthsThe SPISE-R is comprised of 46 questions that uses a 7-point Likert scale to query parents' beliefs, knowledge, confidence, and actions relevant to supporting their child's auditory access and spoken language development. The total average score will range from 1 to 7 with 7 indicating the highest score / highest level of parental involvement and self efficacy.
Patient Health Questionnaire (PHQ-8)up to 8 monthsPHQ-8 has 8 items rated on a scale from not at all (0) to nearly every day (3), with higher scores indicating greater frequency of depressive symptoms. The sum of the items indicates the overall level of depressive symptoms indicating mild (5-9), moderate (10-14), moderately severe (15-19), and severe depressive symptoms (20- 24).
Generalized Anxiety Disorder-7 (GAD-7)up to 8 monthsGAD-7 is a 7-item self-report questionnaire of anxiety symptomatology in the past 14 days. Respondents rate the frequency of each item during the past two weeks on a 0-3-point scale ranging from not at all (0) to nearly every day (3). The sum of the items indicates the overall level of anxiety symptoms indicating mild (0-4), moderate (5-9), moderately severe (10-14), and severe (15- 21).
Quality of Life- CI (QoL-CI)up to 8 monthsQoL-CI is scored 0-100 with higher scores indicating better quality of life.
Cochlear Implant Quality of Life-35 Profile (CIQOL-35 Profile)up to 8 monthsCIQOL-35 Profile is a 35 item questionnaire with a total score ranging from 0-100% with a higher score indicating a higher level of functional ability with a cochlear implant
Parenting Stress Index/Short Form (PSI)up to 8 monthsParenting Stress Index/Short Form (PSI) contains 36 items rated on a 6-point Likert scale (1 = Strongly Disagree to 5 = Strongly Agree) and a total score. Higher scores indicate increased parenting stress.
Parenting Stress-CIup to 8 monthsParenting Stress-CI is completed by the parent and scored from not at all stressful (0) to very stressful (3) with higher scores indicating greater degrees of parenting stress. For parents of children 0-5 years, there are 15 items. For parents of children 6-12 years there are 8 items.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026